Mikhail Blagosklonny Works For Roswell Park Cancer Institute

In 2009, Mikhail was appointed to serve as Roswell Park Cancer Institute’s professor of Oncology. The distinguished physician-scientist has authored more than 170 research articles, book chapters and reviews. In addition, Mikhail is the Founding Editor of Cell Cycle where he also serves as the Editor-in-Chief. The accomplished researcher is the Associate Editor of PLOS ONE, American Journal of Pathology, Cancer Biology & Therapy, Cell Death & Differentiation, Cancer Research, International Journal of Cancer and Autophagy. Most of these journals focus on cancer and aging.

His research focuses on cellular and molecular biology, and clinical investigations, including cell cycle, mitosis, apoptosis, tumor suppressors, ontogenesis and drug resistance. In addition, Mikhail zeroes in on anticancer therapeutics, especially converting basic science into innovative anticancer strategies. He has also researched on signal transduction in aging. The senior vice president of basic science and chairperson of the Cell Stress Biology’s department at Roswell Park Institute, Andrei Gudkov, posited that Mikhail is a pre-eminent researcher. View Mikhail’s profile in LinkedIn

Andrei asserts that Blagosklonny has played an instrumental role in developing new anti-cancer strategies and innovative cancer therapies. The institution seeks to share ideas and approaches that can be used to protect normal cells from chemotherapy and radiotherapy. Mikhail is credited for authoring the hyper-function theory of aging and anti-cancer approaches known as cell-cyclotheraphy and chemotherapeutic engineering. The scientist firmly believes that cancer can be cured. To this end, he has been a staunch supporter of Rapamycin, a potential cancer-curing drug. Rapamycin is known to extend the life of cancer patients.

The professor is an alumnus of the First Pavloc State Medical University where he graduated with his MD in Internal Medicine. In addition, Mikhail Blagosklonny returned to the same institution to pursue his PhD in Experimental Medicine and Cardiology. In 2002, the scholar was appointed to serve as the associate professor of medicine at the renowned Valhalla-based New York Medical College. At Ordway Research Institute, Blagosklonny worked as the chief scientist. By virtue of working for different leading institutions, Mikhail has gained extensive experience and knowledge on various fronts. To this end, he has been able to provide transformative leadership at the Roswell Park Institute. Follow Mikhail on Loop

Leave a Reply

Your email address will not be published. Required fields are marked *